Physician

Tahsin Khundkar, M.D.

According to 2025 Medicare claims, Tahsin Khundkar, M.D. (NPI: 1811347859) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is PENNSYLVANIA RETINA SPECIALISTS PC (NPI: 1568428126; TIN: 232152842) and primary practice location at 17011-1776.

Khundkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 657 traditional Medicare patients, billed 16,995 HCPCS/CPT codes, and received $1,562,076 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 504 prescription claims across 158 beneficiaries totaling $21,871 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 20 records totaling $448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,379 to $1,562,076. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $426 and ending at $21,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$790K$1.6M2020 Medicare payment: $2,379 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,958 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $157,991 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,579,147 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,562,076 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201818$2,379
20214150$4,958
20223181,177$157,991
202360013,164$1,579,147
202465716,995$1,562,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$98K2016 Drug cost: $426 (USD; Tot_Drug_Cst)2017 Drug cost: $6,237 (USD; Tot_Drug_Cst)2018 Drug cost: $64,437 (USD; Tot_Drug_Cst)2019 Drug cost: $98,491 (USD; Tot_Drug_Cst)2020 Drug cost: $39,782 (USD; Tot_Drug_Cst)2021 Drug cost: $8,192 (USD; Tot_Drug_Cst)2022 Drug cost: $14,932 (USD; Tot_Drug_Cst)2023 Drug cost: $33,838 (USD; Tot_Drug_Cst)2024 Drug cost: $21,871 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R13$426
201763151$6,237
2018113445$64,437
2019169735$98,491
2020129611$39,782
202182224$8,192
202280210$14,932
2023165586$33,838
2024158504$21,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1801,410$655
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more284373$88
67028Injection of drug into eye298861$85
92014Established patient complete exam of visual system130135$75
92134Imaging of retina5291,217$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1544,054$4,772
ProlensaBromfenac Sodium13439$4,522
Bromfenac SodiumBromfenac Sodium21793$3,984
Ketorolac TromethamineKetorolac Tromethamine511,609$1,071
Atropine SulfateAtropine Sulfate391,540$930

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$448Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tahsin Khundkar, M.D.?

Tedicare shows public-source Medicare data for Tahsin Khundkar, M.D. (NPI 1811347859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tahsin Khundkar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tahsin Khundkar, M.D.?

Tahsin Khundkar, M.D. is linked to PENNSYLVANIA RETINA SPECIALISTS PC (billing NPI 1568428126) in the available physician profile data.

Does Tahsin Khundkar, M.D. have Open Payments data?

Tahsin Khundkar, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.